HDAC2 and neoplasm: In previous studies, low CBX7 expression may be involved in promoting the tumor metastasis, in which CBX7 binds to the histone deacetylase 2 and inhibits its activity, leading to the histone deacetylation in the E-cad promoter and finally increasing the E-cad expression [13,15].